Creating a future worth living. For patients. Worldwide. Every day.
Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which approximately 4.1 million patients worldwide regularly undergo dialysis treatment. United by a shared purpose of creating a future worth living for chronically and critically ill people, we care for more than 332,000 dialysis patients around the globe. Their well-being always comes first.
It is our mission to provide the best possible care for a growing number of patients sustainably in diverse health care systems. As a vertically integrated company, our portfolio encompasses a comprehensive range of high-quality health care products and services as well as various dialysis treatment options for both in-center and home dialysis.
2023 was a year full of fundamental transformation that we successfully mastered as a company. We are proud of our achievements and have laid the foundation for sustainable profitable growth, and to continue meeting our high standards in shaping the future of kidney care for the benefit of our patients.
Solid organic growth
Exceeding top end of outlook range
Growth driven by favorable business development
Dividend per share